Cytokinetics Inc (CYTK)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	1,107,940	628,051	795,186	535,672	474,221
Total current liabilities	US$ in thousands	179,674	102,678	84,617	71,860	31,199
Current ratio		6.17	6.12	9.40	7.45	15.20

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,107,940K ÷ $179,674K
= 6.17

Based on the provided data, the current ratio of Cytokinetics Inc has fluctuated over the years. As of December 31, 2020, the current ratio stood at 15.20, indicating a strong ability to cover short-term obligations with current assets. However, this ratio decreased to 7.45 by December 31, 2021, which may suggest a reduction in liquidity.

Subsequently, by December 31, 2022, the current ratio improved to 9.40, signaling a better ability to meet short-term liabilities. However, there was a decline in the ratio to 6.12 by December 31, 2023, which could indicate some challenges in managing short-term obligations.

As of December 31, 2024, the current ratio slightly increased to 6.17, but it still remains below the 2020 levels. Overall, the current ratio trend of Cytokinetics Inc reflects variations in liquidity and the company's ability to meet its short-term financial obligations over the years.